Walleye Capital’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.6K Buy
+224
New +$23.2K ﹤0.01% 4363
2025
Q4
Sell
-3,810
Closed -$484K 4688
2025
Q3
$484K Sell
3,810
-2,712
-42% -$323K ﹤0.01% 2637
2025
Q2
$800K Buy
6,522
+6,271
+2,498% +$716K ﹤0.01% 2234
2025
Q1
$25.4K Sell
251
-2,377
-90% -$232K ﹤0.01% 3974
2024
Q4
$243K Buy
2,628
+662
+34% +$65K ﹤0.01% 3608
2024
Q3
$190K Sell
1,966
-4,113
-68% -$370K ﹤0.01% 4038
2024
Q2
$522K Buy
6,079
+3,645
+150% +$306K ﹤0.01% 3479
2024
Q1
$201K Buy
+2,434
New +$178K ﹤0.01% 3974
2023
Q4
Sell
-721
Closed -$48.4K 5084
2023
Q3
$48.4K Buy
+721
New +$49.6K ﹤0.01% 4198
2022
Q2
Sell
-3,660
Closed -$207K 2463
2022
Q1
$207K Sell
3,660
-3,660
-50% -$191K 0.01% 1505
2021
Q4
$380K Buy
+7,320
New +$378K 0.01% 1124
2020
Q1
Sell
-1,395
Closed -$77K 1130
2019
Q4
$77K Buy
+1,395
New +$75.7K 0.01% 1419

Other funds holding EHC

Walleye Capital's EHC Position: Q2 2026 in Review

Walleye Capital opened a new position in Encompass Health (EHC) in Q2 2026: 224 shares worth $22.6K. The stake represents ﹤0.01% of the portfolio and ranks #4363 among its holdings. This is a return to the name: Walleye Capital previously reported a position in EHC as recently as Q3 2025.

Walleye Capital first reported a position in EHC in Q4 2019 and has held it in 12 quarters since. The position peaked at $800K in Q2 2025. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Walleye Capital held 224 shares of Encompass Health worth $22.6K as of Q2 2026.
  • Encompass Health was a new Walleye Capital position in Q2 2026.
  • Encompass Health made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4363 holding.
  • Walleye Capital first reported a position in Encompass Health in Q4 2019 and has held it in 12 quarters since.
  • Walleye Capital's Encompass Health position peaked at $800K in Q2 2025.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.